ARCHIVES

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

Abstracts Of Papers From Copenhagen Leukemia Symposium

October 31, 1975

Niccotine Reports As Aiding Metastasis

August 22, 1986

SBIR Solicitation Issued

September 13, 1996

FDA, NCI, Congress Shape Pediatric Drug Development Proposals

April 11, 2003

‘Meta-analysis’ Of Early Breast Cancer Trials finds Adjuvant Therapy Significantly Prolongs Life

January 10, 1992

ASCO Recommends Against Chemo In Stage II Colon Cancer

June 25, 2004